| Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ... New England Journal of Medicine 376 (6), 536-547, 2017 | 703 | 2017 |
| Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 SGE Marsh, P Parham, B Dupont, DE Geraghty, J Trowsdale, D Middleton, ... Immunogenetics 55, 220-226, 2003 | 598 | 2003 |
| Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes KC Hsu, CA Keever-Taylor, A Wilton, C Pinto, G Heller, K Arkun, ... Blood 105 (12), 4878-4884, 2005 | 574 | 2005 |
| Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets KC Hsu, XR Liu, A Selvakumar, E Mickelson, RJ O’Reilly, B Dupont The journal of immunology 169 (9), 5118-5129, 2002 | 568 | 2002 |
| The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism KC Hsu, S Chida, DE Geraghty, B Dupont Immunological reviews 190 (1), 40-52, 2002 | 559 | 2002 |
| HLA-C–dependent prevention of leukemia relapse by donor activating KIR2DS1 JM Venstrom, G Pittari, TA Gooley, JH Chewning, S Spellman, ... New England Journal of Medicine 367 (9), 805-816, 2012 | 483 | 2012 |
| HLA alleles determine differences in human natural killer cell responsiveness and potency S Kim, JB Sunwoo, L Yang, T Choi, YJ Song, AR French, A Vlahiotis, ... Proceedings of the National Academy of Sciences 105 (8), 3053-3058, 2008 | 311 | 2008 |
| Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment N Tarek, JB Le Luduec, MM Gallagher, J Zheng, JM Venstrom, ... The Journal of clinical investigation 122 (9), 3260-3270, 2012 | 256 | 2012 |
| TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation S Kesh, NY Mensah, P Peterlongo, D Jaffe, K Hsu, M van den Brink, ... Annals of the New York Academy of Sciences 1062 (1), 95-103, 2005 | 255 | 2005 |
| Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands J Yu, G Heller, J Chewning, S Kim, WM Yokoyama, KC Hsu The Journal of Immunology 179 (9), 5977-5989, 2007 | 249 | 2007 |
| KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy KC Hsu, T Gooley, M Malkki, C Pinto-Agnello, B Dupont, JD Bignon, ... Biology of blood and marrow transplantation 12 (8), 828-836, 2006 | 238 | 2006 |
| Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation J Shi, G Tricot, S Szmania, N Rosen, TK Garg, PA Malaviarachchi, ... British journal of haematology 143 (5), 641-653, 2008 | 236 | 2008 |
| KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro JH Chewning, CN Gudme, KC Hsu, A Selvakumar, B Dupont The Journal of Immunology 179 (2), 854-868, 2007 | 214 | 2007 |
| Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation S Prockop, E Doubrovina, S Suser, G Heller, J Barker, P Dahi, MA Perales, ... The Journal of clinical investigation 130 (2), 733-747, 2020 | 185 | 2020 |
| Natural killer cell education and the response to infection and cancer therapy: stay tuned JE Boudreau, KC Hsu Trends in immunology 39 (3), 222-239, 2018 | 179 | 2018 |
| Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell–depleted allogeneic hematopoietic … J Yu, JM Venstrom, XR Liu, J Pring, RS Hasan, RJ O'Reilly, KC Hsu Blood, The Journal of the American Society of Hematology 113 (16), 3875-3884, 2009 | 155 | 2009 |
| HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation EW Petersdorf, TA Gooley, M Malkki, AP Bacigalupo, A Cesbron, ... Blood, The Journal of the American Society of Hematology 124 (26), 3996-4003, 2014 | 152 | 2014 |
| Phase II study of haploidentical natural killer cell infusion for treatment of relapsed or persistent myeloid malignancies following allogeneic hematopoietic cell transplantation B Shaffer, JB Le Luduec, C Forlenza, AA Jakubowski, MA Perales, ... Biol Blood Marrow Transplant 22, 705-709, 2016 | 142 | 2016 |
| KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk … JM Venstrom, J Zheng, N Noor, KE Danis, AW Yeh, IY Cheung, B Dupont, ... Clinical Cancer Research 15 (23), 7330-7334, 2009 | 140 | 2009 |
| Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation JM Venstrom, TA Gooley, S Spellman, J Pring, M Malkki, B Dupont, ... Blood, The Journal of the American Society of Hematology 115 (15), 3162-3165, 2010 | 137 | 2010 |
